Developing Novel Therapies to Prevent Atherosclerosis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Vascular Medicine".
Deadline for manuscript submissions: closed (5 June 2019) | Viewed by 48658
Special Issue Editor
Special Issue Information
Dear Colleagues,
Despite the vast amount of clinical and pre-clinical research that has been invested in the prevention of atherosclerosis, it continues to affect more than 30% of Western populations. The identification of new targets that regulate atherosclerosis, and the development of more plaque modifying therapies, are therefore required. The mechanisms that underlie atherosclerosis are still not fully understood, in particular, how these mechanisms may change with the stage of atherosclerosis is under appreciated. This Special Issue seeks original research manuscripts and reviews that address a range of topics that are related to the use of current therapies, their failures and/or successes, and new up and-and coming therapies. The identification of new regulators of atherosclerosis based on preclinical findings is also welcomed.
Dr. Christina Bursill
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- New mechanisms of atherosclerosis
- Plaque inflammation
- Anti-inflammatory therapies
- Plaque-modifying therapies
- Macrophage regulation
- Lipoprotein regulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.